Clinical Study To Evaluate The Efficacy AndSafety Of Psoramit Ointment In patients suffering from mild tomoderate Psoriasis
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2019/09/021423
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Subject with symptoms of mild to moderate psoriasis with PASI score <10
Subject diagnosed with Mild to moderate chronic plaque psoriasis with
Palmoplantar psoriasis, Guttate psoriasis, Flexural psoriasis
Age >18 to 65 years, both male and female subjects.
Physician Global Assessment score of <2
Patients willing to sign inform consent document.
Patients with Pustular psoriasis, Erythrodermic psoriasis and psoriatic
arthritis
Subjects treated with other medications / steroids.
Significant medical problems such as uncontrolled hypertension /
congestive heart failure or any other medication condition
Pregnant & Breast feeding Women.
History of ongoing, chronic or recurrent infectious disease /
lymphoproliferative disease or history of malignancy of any organ
system within the past 5 years.
History of Alcohol or smoking abuse.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method